Pharmaceutical composition containing botulinum neurotoxin
Method for treating a disease, condition, or syndrome in a subject comprising administering, to a subject in need thereof, a solid or liquid pharmaceutical composition comprising: (a) a high purity botulinum neurotoxin or a complex comprising botulinum neurotoxin, wherein the botulinum neurotoxin is of type A, B, C, D, E, F or G; and (b) a surfactant; wherein the composition does not comprise albumin or a polysaccharide.
1. A method for treating wrinkles comprising administering to a subject in need thereof a composition comprising:
(a) a high purity botulinum neurotoxin or a complex comprising botulinum neurotoxin, wherein the botulinum neurotoxin is of type A, B, C, D, E, F or G; and
(b) a surfactant;
wherein the composition does not comprise albumin or a polysaccharide.
2. The method of claim 1 , wherein the composition further comprises sodium chloride.
3. The method of claim 1 , wherein the composition further comprises a buffer capable of maintaining an aqueous solution at a pH between 5.5 and 7.5.
4. The method of claim 1 , wherein the composition further comprises a disaccharide.
5. The method of claim 1 , wherein the botulinum neurotoxin is a botulinum neurotoxin type A.
6. The method of claim 1 , wherein the botulinum neurotoxin complex or high purity botulinum neurotoxin is administered in a therapeutically efficient quantity.
7. The method of claim 1 , for treating glabellar frown lines.
8. The method of claim 1 , for treating facial wrinkles.